Avid Bioservices Inc 's ability to collect accounts receivable sequentially worsen to 8.08, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Average collection period, for Avid Bioservices Inc 's accounts receivable remained unchanged at 45 days, in the Oct 31 2024 quarter.

If we take a look into Healthcare sector 330 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Oct 31 2024 from 1460 to 2274.

What is Receivable Turnover Ratio?
What is Avid Bioservices Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CDMO Receivables Turnover Ratio	(Oct 31 2024) II. Quarter	(Jul 31 2024) I. Quarter	(Apr 30 2024) IV. Quarter	(Jan 31 2024) III. Quarter	(Oct 31 2023) II. Quarter
Y / Y Receivable Change	37.61 %	29.32 %	-9.04 %	25.04 %	-34.99 %
Y / Y Revenue Change	32.16 %	8.28 %	11.5 %	-12.19 %	-27.11 %
Receivable Turnover Ratio (TTM)	8.08	8.19	8.6	8.12	8.9
CDMO's Total Ranking	# 2274	# 1460	# 2264	# 2653	# 2658
Accounts Receivable average collection period days	45	45	42	45	41
Seq. Receivable Change	-12.17 %	25.94 %	-10.22 %	38.56 %	-17.46 %
Seq. Revenue Change	-16.66 %	-7.65 %	30.31 %	31.77 %	-31.71 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 91
Healthcare Sector	# 331
Overall Market	# 2274

Receivable Turnover Ratio Statistics
High	Average	Low
0.72	0.46	0.26
(Jul 31 2017)		(Oct 31 2014)

CDMO Company Profile • Back to CDMO Efficiency Comparisons • Compare CDMO Receivables Turnover Ratio to its Competitors

Financial Statements
Avid Bioservices Inc 's Accounts Receivable	$ 18 Millions	Visit CDMO's Balance sheet
Avid Bioservices Inc 's Sales TTM	$ 151 Millions	Visit CDMO's Income Statement
Sources of CDMO's Revenues		Visit CDMO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CDMO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CDMO's Growth Rates	CDMO's Roa	CDMO's Inventory Turnover Ratio	CDMO's Dividend Comparisons
CDMO's Profitability Ratios	CDMO's Roi	CDMO's Asset Turnover Ratio	CDMO's Dividend Growth
CDMO's Valuation Ratios	CDMO's Roe	CDMO's Financial Strength Ratios	CDMO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Oct 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Oct 31 2024	Receivable at quarter ending Oct 31 2024
U S Physical Therapy Inc	22.39	$ 645.699 Millions	$ 28.841 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions
One World Products Inc	22.21	$ 0.003 Millions	$ 0.000 Millions
Innovative Eyewear Inc	21.65	$ 1.562 Millions	$ 0.072 Millions
Ginkgo Bioworks Holdings Inc	21.39	$ 217.951 Millions	$ 10.188 Millions
Ethema Health Corporation	21.31	$ 5.675 Millions	$ 0.266 Millions
Co diagnostics Inc	19.94	$ 7.321 Millions	$ 0.367 Millions
Nutriband Inc	19.66	$ 2.022 Millions	$ 0.103 Millions
Medinotec Inc	19.03	$ 8.385 Millions	$ 0.441 Millions
Kiniksa Pharmaceuticals International Plc	18.60	$ 384.098 Millions	$ 20.650 Millions
Pulmatrix Inc	18.56	$ 10.005 Millions	$ 0.539 Millions
Milestone Scientific Inc	18.54	$ 8.862 Millions	$ 0.478 Millions
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Vireo Growth Inc.	17.70	$ 98.534 Millions	$ 5.568 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Silence Therapeutics Plc	17.27	$ 43.010 Millions	$ 2.490 Millions
Innovage Holding Corp	17.01	$ 786.512 Millions	$ 46.249 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Arvinas Inc	16.48	$ 161.100 Millions	$ 9.775 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions
Bgm Group Ltd	16.31	$ 24.115 Millions	$ 1.478 Millions
Nexalin Technology Inc	16.24	$ 0.162 Millions	$ 0.010 Millions
Precipio inc	16.07	$ 17.411 Millions	$ 1.084 Millions
Sangamo Therapeutics Inc	15.97	$ 52.291 Millions	$ 3.274 Millions
Icu Medical Inc	14.80	$ 2,340.754 Millions	$ 158.125 Millions
Inmed Pharmaceuticals Inc	14.57	$ 4.284 Millions	$ 0.294 Millions
Biofrontera Inc	14.26	$ 61.432 Millions	$ 4.308 Millions
Valion Bio Inc	14.02	$ 0.957 Millions	$ 0.068 Millions

Date modified: 2026-08-29T17:15:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.